Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2008 7
2009 6
2010 3
2011 4
2012 5
2013 2
2014 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
NRF2 and cancer: the good, the bad and the importance of context.
Sporn MB, Liby KT. Sporn MB, et al. Nat Rev Cancer. 2012 Jul 19;12(8):564-71. doi: 10.1038/nrc3278. Nat Rev Cancer. 2012. PMID: 22810811 Free PMC article. Review.
New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress.
Sporn MB, Liby KT, Yore MM, Fu L, Lopchuk JM, Gribble GW. Sporn MB, et al. J Nat Prod. 2011 Mar 25;74(3):537-45. doi: 10.1021/np100826q. Epub 2011 Feb 10. J Nat Prod. 2011. PMID: 21309592 Free PMC article. Review.
Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration.
Cano M, Thimmalappula R, Fujihara M, Nagai N, Sporn M, Wang AL, Neufeld AH, Biswal S, Handa JT. Cano M, et al. Vision Res. 2010 Mar 31;50(7):652-64. doi: 10.1016/j.visres.2009.08.018. Epub 2009 Aug 22. Vision Res. 2010. PMID: 19703486 Free PMC article. Review.
Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer.
Liby KT, Royce DB, Risingsong R, Williams CR, Maitra A, Hruban RH, Sporn MB. Liby KT, et al. Cancer Prev Res (Phila). 2010 Nov;3(11):1427-34. doi: 10.1158/1940-6207.CAPR-10-0197. Epub 2010 Oct 19. Cancer Prev Res (Phila). 2010. PMID: 20959520 Free PMC article.
Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.
Choi SH, Kim BG, Robinson J, Fink S, Yan M, Sporn MB, Markowitz SD, Letterio JJ. Choi SH, et al. J Clin Invest. 2014 Jun;124(6):2472-82. doi: 10.1172/JCI69672. Epub 2014 May 16. J Clin Invest. 2014. PMID: 24837432 Free PMC article.
The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient mice.
To C, Kim EH, Royce DB, Williams CR, Collins RM, Risingsong R, Sporn MB, Liby KT. To C, et al. Cancer Prev Res (Phila). 2014 Jul;7(7):698-707. doi: 10.1158/1940-6207.CAPR-14-0047. Epub 2014 May 9. Cancer Prev Res (Phila). 2014. PMID: 24817481 Free PMC article.
CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.
Kim EH, Deng C, Sporn MB, Royce DB, Risingsong R, Williams CR, Liby KT. Kim EH, et al. Cancer Prev Res (Phila). 2012 Jan;5(1):89-97. doi: 10.1158/1940-6207.CAPR-11-0359. Epub 2011 Sep 20. Cancer Prev Res (Phila). 2012. PMID: 21933912 Free PMC article.
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR.
Yore MM, Kettenbach AN, Sporn MB, Gerber SA, Liby KT. Yore MM, et al. PLoS One. 2011;6(7):e22862. doi: 10.1371/journal.pone.0022862. Epub 2011 Jul 27. PLoS One. 2011. PMID: 21818401 Free PMC article.
The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice.
Tran K, Risingsong R, Royce D, Williams CR, Sporn MB, Liby K. Tran K, et al. Cancer Prev Res (Phila). 2012 May;5(5):726-34. doi: 10.1158/1940-6207.CAPR-11-0404. Epub 2012 Mar 8. Cancer Prev Res (Phila). 2012. PMID: 22401982 Free article.
29 results
Jump to page
Feedback